Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy ; volume:23 ; number:1 ; day:24 ; month:2 ; year:2023 ; pages:1-10 ; date:12.2023
Cancer imaging ; 23, Heft 1 (24.2.2023), 1-10, 12.2023
- Urheber
-
Yan, Wenbin
Sun, Chunhua
Ou, Xiaomin
Hu, Chaosu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40644-023-00536-z
- URN
-
urn:nbn:de:101:1-2023070321260202557000
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yan, Wenbin
- Sun, Chunhua
- Ou, Xiaomin
- Hu, Chaosu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy
Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma
Metastatic Nasopharyngeal Carcinoma: Outcome from Cancer Institute, Chennai
Contemporary Management of Metastatic Gastrointestinal Stromal Tumors: Systemic and Locoregional Approaches
Risk-adapted locoregional radiotherapy strategies based on a prognostic nomogram for de novo metastatic nasopharyngeal carcinoma patients treated with chemoimmunotherapy
Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis
Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma
Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
Prognostic value of pre-treatment [18F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy
Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma
Metastatic Nasopharyngeal Carcinoma: Outcome from Cancer Institute, Chennai
Contemporary Management of Metastatic Gastrointestinal Stromal Tumors: Systemic and Locoregional Approaches
Risk-adapted locoregional radiotherapy strategies based on a prognostic nomogram for de novo metastatic nasopharyngeal carcinoma patients treated with chemoimmunotherapy
Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis
Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma
Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab
Prognostic value of pre-treatment [18F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy
Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma
Metastatic Nasopharyngeal Carcinoma: Outcome from Cancer Institute, Chennai
Contemporary Management of Metastatic Gastrointestinal Stromal Tumors: Systemic and Locoregional Approaches
Risk-adapted locoregional radiotherapy strategies based on a prognostic nomogram for de novo metastatic nasopharyngeal carcinoma patients treated with chemoimmunotherapy
Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis
Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma
Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment
68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Pre-treatment metastatic growth rate is associated with clinical outcome in patients with metastatic renal cell carcinoma treated with nivolumab